These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 26244500)
1. Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease. Liao YC; Liu YT; Tsai PC; Chang CC; Huang YH; Soong BW; Lee YC PLoS One; 2015; 10(8):e0133423. PubMed ID: 26244500 [TBL] [Abstract][Full Text] [Related]
2. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy. Abe A; Hayasaka K J Hum Genet; 2009 May; 54(5):310-2. PubMed ID: 19329989 [TBL] [Abstract][Full Text] [Related]
4. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. James PA; Cader MZ; Muntoni F; Childs AM; Crow YJ; Talbot K Neurology; 2006 Nov; 67(9):1710-2. PubMed ID: 17101916 [TBL] [Abstract][Full Text] [Related]
5. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease. Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905 [TBL] [Abstract][Full Text] [Related]
7. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524 [TBL] [Abstract][Full Text] [Related]
8. [A novel mutation in glycyl-tRNA synthetase caused Charcot-Marie-Tooth disease type 2D with facial and respiratory muscle involvement]. Kawakami N; Komatsu K; Yamashita H; Uemura K; Oka N; Takashima H; Takahashi R Rinsho Shinkeigaku; 2014; 54(11):911-5. PubMed ID: 25420567 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Del Bo R; Locatelli F; Corti S; Scarlato M; Ghezzi S; Prelle A; Fagiolari G; Moggio M; Carpo M; Bresolin N; Comi GP Neurology; 2006 Mar; 66(5):752-4. PubMed ID: 16534118 [TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease. Yalcouyé A; Diallo SH; Coulibaly T; Cissé L; Diallo S; Samassékou O; Diarra S; Coulibaly D; Keita M; Guinto CO; Fischbeck K; Landouré G; Mol Genet Genomic Med; 2019 Jul; 7(7):e00782. PubMed ID: 31173493 [TBL] [Abstract][Full Text] [Related]
11. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease. Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614 [TBL] [Abstract][Full Text] [Related]
13. Phenotype of Charcot-Marie-Tooth disease Type 2. Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546 [TBL] [Abstract][Full Text] [Related]
14. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612 [TBL] [Abstract][Full Text] [Related]
15. A novel mutation of the glycyl-tRNA synthetase (GARS) gene associated with Charcot-Marie-Tooth type 2D in a Chinese family. Sun A; Liu X; Zheng M; Sun Q; Huang Y; Fan D Neurol Res; 2015 Sep; 37(9):782-7. PubMed ID: 26000875 [TBL] [Abstract][Full Text] [Related]
16. Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy. Hsiao CT; Tsai PC; Lin CC; Liu YT; Huang YH; Liao YC; Huang HW; Lin KP; Soong BW; Lee YC PLoS One; 2016; 11(1):e0147677. PubMed ID: 26815532 [TBL] [Abstract][Full Text] [Related]
17. Dimerization is required for GARS-mediated neurotoxicity in dominant CMT disease. Malissovas N; Griffin LB; Antonellis A; Beis D Hum Mol Genet; 2016 Apr; 25(8):1528-42. PubMed ID: 27008886 [TBL] [Abstract][Full Text] [Related]
18. Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V. Lee HJ; Park J; Nakhro K; Park JM; Hur YM; Choi BO; Chung KW J Peripher Nerv Syst; 2012 Dec; 17(4):418-21. PubMed ID: 23279345 [TBL] [Abstract][Full Text] [Related]
19. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914 [TBL] [Abstract][Full Text] [Related]
20. SIRT2-knockdown rescues GARS-induced Charcot-Marie-Tooth neuropathy. Zhao Y; Xie L; Shen C; Qi Q; Qin Y; Xing J; Zhou D; Qi Y; Yan Z; Lin X; Dai R; Lin J; Yu W Aging Cell; 2021 Jun; 20(6):e13391. PubMed ID: 34053152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]